Spectrum.Life has followed its recent rebrand with a €17 million ($18.5 million) financing that will be used to expand the reach and scale of its mental health and wellbei
GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial.<